NCT03475810

Brief Summary

The aim of the study is to evaluate the efficacy of virtual reality glasses on anxiety of the patients who underwent operations under spinal anesthesia during peroperative period. Both control group and VR group will be carry out STAI- Traıt anxiety test before operation and trait test after operation. Patients will be perform spinal anesthesia after standard sedation administration. After block reach adequate level for operation patients in VR group will wear the glasses and started to watch a documentary about birds and a sedative music by the headset. Patients in Control group will take standard anesthesia care. Hemodynamic changes (systemic blood pressure, heart rate, respiration rate and pSPO2) will be record in both groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 7, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 17, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 23, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

September 7, 2023

Status Verified

September 1, 2023

Enrollment Period

8 months

First QC Date

March 17, 2018

Last Update Submit

September 5, 2023

Conditions

Keywords

VIRTUAL REALITYANXIETYSPINAL ANESTHESIA

Outcome Measures

Primary Outcomes (1)

  • State Anxiety Test

    State Anxiety test will be perform at postop care unit

    postoperative 20th min.

Secondary Outcomes (18)

  • Total tolerance time of Virtual Reality glasses

    intraoperative

  • incidence of vomiting

    intraoperative

  • incidence of nausea

    intraoperative

  • incidence of dizziness

    intraoperative

  • incidence of headache

    intraoperative

  • +13 more secondary outcomes

Study Arms (2)

VR GROUP

EXPERIMENTAL

Patients watches 3D documentary videos on virtual reality glasses

Device: Virtual RealityDrug: Midazolam

midazolam

ACTIVE COMPARATOR

Patients do not watch virtual reality videos but will be administered iv sedative drugs before spinal attempt.

Drug: Midazolam

Interventions

Patients will wear virtual reality glasses and start watching 3 D video after confirmation of adequate motor and sensorial block.

Also known as: VR
VR GROUP

1-2 mg midazolam will be administered before spinal punction performed.

Also known as: Demizolam
VR GROUPmidazolam

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18
  • Patients who undergo surgery under spinal anesthesia
  • American Society of Anesthesiologists (ASA) physical status classification I-III

You may not qualify if:

  • patients undergo urgent operations
  • patients have psychiatric disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Derince Research and Training Hospital

Kocaeli, 41900, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Anxiety Disorders

Interventions

Midazolam

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

BenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • Ayse Zeynep Turan, MD

    Derince Research and Training Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

March 17, 2018

First Posted

March 23, 2018

Study Start

November 7, 2017

Primary Completion

July 1, 2018

Study Completion

July 1, 2018

Last Updated

September 7, 2023

Record last verified: 2023-09

Locations